Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
CO ›
COMBENCIL
Trademark search for:
COMBENCIL
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-12-20 — Application filed
2012-12-24 — Application filed
2013-01-08 — Application filed
2013-04-08 — Final disposition recorded
2013-04-08 — Final disposition recorded
2013-04-08 — Assigned to examiner
2013-04-08 — Final disposition recorded
2013-09-25 — Office action issued
2013-09-25 — Correspondence received in law office
2013-09-26 — Teas/email correspondence entered
2013-10-01 — Approved for pub - principal register
2013-10-16 — Assigned to lie
2013-10-16 — Law office publication review completed
2013-10-30 — Notification of notice of publication e-mailed
2013-11-19 — Published for opposition
2013-11-19 — Official gazette publication confirmation e-mailed
2014-01-14 — Noa e-mailed - sou required from applicant
2014-07-01 — Sou teas extension received
2014-07-01 — Sou extension 1 filed
2014-07-01 — Sou extension 1 granted
2014-07-03 — Notice of approval of extension request e-mailed
2015-01-06 — Sou teas extension received
2015-01-06 — Sou extension 2 filed
2015-02-17 — Case assigned to intent to use paralegal
2015-02-19 — Sou extension 2 granted
2015-02-20 — Notice of approval of extension request e-mailed
2015-06-09 — Sou teas extension received
2015-06-09 — Sou extension 3 filed
2015-06-25 — Sou extension 3 granted
2015-06-26 — Notice of approval of extension request e-mailed
2015-12-22 — Sou teas extension received
2015-12-22 — Sou extension 4 filed
2016-01-25 — Sou extension 4 granted
2016-01-26 — Notice of approval of extension request e-mailed
2016-06-09 — Sou teas extension received
2016-06-09 — Sou extension 5 filed
2016-06-28 — Sou extension 5 granted
2016-06-29 — Notice of approval of extension request e-mailed
2016-08-08 — Teas petition to amend basis received
2016-08-24 — Petition to director - change basis - granted
2016-08-24 — Assigned to petition staff
2016-08-24 — Attorney review/decision on amendment required
2016-09-06 — Noa cancelled; republication required
2016-09-06 — Notice of allowance cancelled
2016-09-21 — Notification of notice of publication e-mailed
2016-10-11 — Published for opposition
2016-10-11 — Official gazette publication confirmation e-mailed
2016-12-27 — Registered-principal register
2019-02-08 — Teas change of correspondence received
2021-07-22 — Attorney/dom.rep.revoked and/or appointed
2021-07-22 — Teas change of domestic representatives address
2021-07-22 — Teas change of owner address received
2021-07-22 — Teas change of correspondence received
2021-07-22 — Applicant/correspondence changes (non-responsive) entered
2021-07-22 — Teas revoke/app/change addr of atty/dom rep received
2021-12-27 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2023-07-07 — Cancelled sec. 8 (6-yr)
2023-07-07 — Final status recorded
Owner Information
AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE
Correspondent
Cara M. Kearney AstraZeneca Pharmaceuticals LP 1800 Concord Pike, A2C Wilmington, DE 19850-5437 UNITED STATES
Filing Details
Filing Date:
2012-12-20
Status Date:
2023-07-07
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.